Each film coated tablet contains:
Bicalutamide USP 50mg
Colour: Titanium Dioxide
Mechanism of action
Bicalutamide is a non-steroidal androgen receptor inhibitor. It competitively inhibits the action of androgens by binding to cytosol and logen receptors in the target tissue. Prostatic carcinoma is known to be androgen sensitive and responds to treatment that counteracts the effects of androgen and / or removes the source of androgen.
GLASODEX BICALUTAMIDE TABLETS USP 50 MG
• For the treatment of Metastic prostate Cancer ( mPC) in men in combination with a gonadotropin – releasing hormone ( GnRH ) analogue or surgical castration at moderate doses.
• For the treatment of Locally advanced prostrate cancer ( LAPC ) in men as a monotherapy in high doses.